86
Participants
Start Date
March 23, 2004
Primary Completion Date
May 1, 2006
Study Completion Date
May 1, 2006
mepolizumab
GSK Investigational Site, St Leonards
GSK Investigational Site, Leuven
GSK Investigational Site, Bern
GSK Investigational Site, Melbourne
GSK Investigational Site, South Brisbane
GSK Investigational Site, West Perth
GSK Investigational Site, Bethesda
GSK Investigational Site, Bad Bramstedt
GSK Investigational Site, Hanover
GSK Investigational Site, Bologna
GSK Investigational Site, Cincinnati
GSK Investigational Site, Madison
GSK Investigational Site, Rochester
GSK Investigational Site, Lille
GSK Investigational Site, Houston
GSK Investigational Site, Denver
GSK Investigational Site, Munich
GSK Investigational Site, Salt Lake City
GSK Investigational Site, San Diego
GSK Investigational Site, Suresnes
GSK Investigational Site, Boston
GSK Investigational Site, Nashville
GSK Investigational Site, Richmond
GSK Investigational Site, Edmonton
GSK Investigational Site, Winnipeg
GSK Investigational Site, Halifax
GSK Investigational Site, Hamilton
GSK Investigational Site, Toronto
GSK Investigational Site, Montreal
Lead Sponsor
GlaxoSmithKline
INDUSTRY